| mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
| mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.9 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.9 |
| mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.9 |
| mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.9 |
| mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.9 |
| mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |